These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 20519352
1. The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma. Cavalier E, Daly AF, Betea D, Pruteanu-Apetrii PN, Delanaye P, Stubbs P, Bradwell AR, Chapelle JP, Beckers A. J Clin Endocrinol Metab; 2010 Aug; 95(8):3745-9. PubMed ID: 20519352 [Abstract] [Full Text] [Related]
2. The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform. Cavalier E, Betea D, Schleck ML, Gadisseur R, Vroonen L, Delanaye P, Daly AF, Beckers A. J Clin Endocrinol Metab; 2014 Mar; 99(3):E453-7. PubMed ID: 24423313 [Abstract] [Full Text] [Related]
3. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism. Caron P, Maiza JC, Renaud C, Cormier C, Barres BH, Souberbielle JC. Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355 [Abstract] [Full Text] [Related]
4. Intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. Kandil E, Alabbas HH, Bansal A, Islam T, Tufaro AP, Tufano RP. Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1206-8. PubMed ID: 20026817 [Abstract] [Full Text] [Related]
5. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves. Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM. J Clin Endocrinol Metab; 2006 Oct; 91(10):3826-9. PubMed ID: 16849415 [Abstract] [Full Text] [Related]
6. Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism. Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Clin Chem; 2006 Apr; 52(4):757-60. PubMed ID: 16497941 [Abstract] [Full Text] [Related]
7. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas. Bhadada SK, Cardenas M, Bhansali A, Mittal BR, Behera A, Chanukya GV, Nahar U, Rao DS. Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640 [Abstract] [Full Text] [Related]
8. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy. Heller KS, Blumberg SN. Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922 [Abstract] [Full Text] [Related]
9. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia. Arakawa T, D'Amour P, Rousseau L, Brossard JH, Sakai M, Kasumoto H, Igaki N, Goto T, Cantor T, Fukagawa M. Clin J Am Soc Nephrol; 2006 May; 1(3):525-31. PubMed ID: 17699255 [Abstract] [Full Text] [Related]
10. Does the final intraoperative PTH level really have to fall into the normal range to signify cure? Reiher AE, Schaefer S, Chen H, Sippel RS. Ann Surg Oncol; 2012 Jun; 19(6):1862-7. PubMed ID: 22203183 [Abstract] [Full Text] [Related]
11. [Surgical treatment of hyperparathyroidism]. Târcoveanu E, Niculescu D, Moldovanu R, Cotea E, Vasilescu A, Dănilă N, Lăzescu D, Ferariu D, Crumpei F, Ichim M, Zbranca E. Chirurgia (Bucur); 2009 Jun; 104(5):531-44. PubMed ID: 19943551 [Abstract] [Full Text] [Related]
12. Non-super-selective venous sampling for persistent hyperparathyroidism using a systemic hypocalcemic challenge. Morris LF, Loh C, Ro K, Wiseman JE, Gomes AS, Asandra A, Wariri S, Yeh MW. J Vasc Interv Radiol; 2012 Sep; 23(9):1191-9. PubMed ID: 22832137 [Abstract] [Full Text] [Related]
13. Critical issues of PTH assays in CKD. Komaba H, Goto S, Fukagawa M. Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701 [Abstract] [Full Text] [Related]
15. Primary hyperparathyroidism from parathyroid microadenoma: specific features and implications for a surgical strategy in the era of minimally invasive parathyroidectomy. Goasguen N, Chirica M, Roger N, Munoz-Bongrand N, Zohar S, Noullet S, de Roquancourt A, Cattan P, Sarfati E. J Am Coll Surg; 2010 Apr; 210(4):456-62. PubMed ID: 20347738 [Abstract] [Full Text] [Related]
16. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Robert JH, Trombetti A, Garcia A, Pache JC, Herrmann F, Spiliopoulos A, Rizzoli R. Ann Surg Oncol; 2005 Jul; 12(7):526-32. PubMed ID: 15889214 [Abstract] [Full Text] [Related]
17. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Paruk IM, Esterhuizen TM, Maharaj S, Pirie FJ, Motala AA. Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345 [Abstract] [Full Text] [Related]
18. Immunoassays for the detection of parathyroid hormone. Jüppner H, Potts JT. J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782 [Abstract] [Full Text] [Related]
19. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B. Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888 [Abstract] [Full Text] [Related]
20. Elevated parathyroid hormone levels after parathyroidectomy for primary hyperparathyroidism. Mizrachi A, Gilat H, Bachar G, Feinmesser R, Shpitzer T. Head Neck; 2009 Nov; 31(11):1456-60. PubMed ID: 19405085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]